Davis's Drug Guide
glecaprevir/pibrentasvir
General
Genetic Implications:
Pronunciation:
glek-a-pre-vir/pi-brent-as-vir
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Maviret
- Mavyret
Ther. Class.
Pharm. Class.
NS5A inhibitors
protease inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Glecaprevir/pibrentasvir." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110508/all/glecaprevir_pibrentasvir.
Vallerand AHA, Sanoski CAC, Quiring CC. Glecaprevir/pibrentasvir. Davis's Drug Guide. F.A. Davis Company; 2024. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110508/all/glecaprevir_pibrentasvir. Accessed November 21, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). Glecaprevir/pibrentasvir. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110508/all/glecaprevir_pibrentasvir
Vallerand AHA, Sanoski CAC, Quiring CC. Glecaprevir/pibrentasvir [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 November 21]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110508/all/glecaprevir_pibrentasvir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - glecaprevir/pibrentasvir
ID - 110508
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110508/all/glecaprevir_pibrentasvir
PB - F.A. Davis Company
ET - 19
DB - Anesthesia Central
DP - Unbound Medicine
ER -
